Analysis of beta-blocker bioconcentration in brown planaria (Girardia dorotocephala) and its effects on regeneration
Production, distribution, and disposal of pharmaceutical products, including beta-blockers, have become a global issue. Beta-blockers are known to persist in the environment months after their release and may result in the disruption of the homeostatic system in non-target organisms. Here, we study the bioconcentration of three of the most commonly used beta-blockers and their effect on the regeneration of Girardia dorotocephala, a freshwater brown planarian. Acute toxicity tests determined LC50s for acebutolol, metoprolol, and propranolol to be 778 mg/L, 711 mg/L, and 111 mg/L, respectively. The quantification and analysis of beta-blocker bioconcentration during acute exposure were performed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). After 4 days of exposure to beta-blockers, the bioconcentration drastically decreased for all three beta-blockers at all exposure levels, suggesting that an effective mechanism to reduce uptake or excrete beta-blockers could be present. Additionally, Girardia dorotocephala were cut proximal to the head and the quality of regeneration was documented from each fragment daily. No significant difference was visually observed after 2 weeks of regeneration between the brown planarians placed in beta-blocker solution and those placed in control solution.
KeywordsBeta-blockers LC-MS/MS Brown planarians Girardia dorotocephala Neoblast
Southern Illinois University Edwardsville supported this work through startup funds, Research Grants for Graduate Students, and through the Undergraduate Research and Creative Activities program.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Bradley HA, Wiysonge CS, Volmink JA, Mayosi BM, Opie LH (2006) How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis. J Hypertens 24(11):2131–2141. https://doi.org/10.1097/01.hjh.0000249685.58370.28 CrossRefGoogle Scholar
- Driever, W., Solnica-Krezel, L., Schier, A. F., Neuhauss, S. C., Malicki, J., Stemple, D. L., … Boggs, C. (1996). A genetic screen for mutations affecting embryogenesis in zebrafish. Development, 123(1), 37–46.Google Scholar
- Larsson DGJ (2008) Drug production facilities – an overlooked discharge source for pharmaceuticals to the environment. In: Kümmerer K (ed) Pharmaceuticals in the Environment. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-74664-5_3
- Maszkowska J, Stolte S, Kumirska J, Łukaszewicz P, Mioduszewska K, Puckowski A, Caban M, Wagil M, Stepnowski P, Białk-Bielińska A (2014) Beta-blockers in the environment: Part I. Mobility and hydrolysis study. Sci Total Environ 493:1112–1121. https://doi.org/10.1016/j.scitotenv.2014.06.023 CrossRefGoogle Scholar
- Neely WB (1980) Chemicals in the environment: distribution, transport, fate, analysis. Marcel Dekker Inc., New York, New YorkGoogle Scholar
- Pagán OR, Coudron T, Kaneria T (2009) The flatworm planaria as a toxicology and behavioral pharmacology animal model in undergraduate research experiences. J Undergrad Neurosci Educ 7(2):A48–A52Google Scholar
- Reddien PW, Sánchez Alvarado A (2004) Fundamentals of planarian regeneration. Annu Rev Cell Dev Biol 20:725–757. https://doi.org/10.1146/annurev.cellbio.20.010403.095114 CrossRefGoogle Scholar